Friday, 4 December 2020

Zydus receives approval from DCGI to commence Phase III clinical trials with Pegylated Interferon alpha-2b in India



source https://www.pharmatutor.org/pharma-news/2020/zydus-receives-approval-from-dcgi-to-commence-phase-iii-clinical-trials-with-pegylated-interferon-alpha-2b-in-india
at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Pharma openings

  Opportunity for M.Pharm, Msc or PhD as Scientist at PGIMER M.Pharmacy or M.Sc 6 Year of Research Experience or PhD with 3 year of Experien...